- Home
- XPON vs RDHL Comparison
XPON vs RDHL Comparison
Compare XPON & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPON | RDHL |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.7M |
| IPO Year | 2022 | 2012 |
Fundamental Metrics
Financial Performance| Metric | XPON | RDHL |
|---|---|---|
| Price | $2.50 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.8K | ★ 869.8K |
| Earning Date | 11-16-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,651,870.00 | N/A |
| Revenue This Year | N/A | $17,592.31 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 71.59 | N/A |
| 52 Week Low | $0.26 | $0.38 |
| 52 Week High | $11.79 | $1.60 |
Technical Indicators
Market Signals| Indicator | XPON | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 29.06 | 43.31 |
| Support Level | $0.51 | $0.38 |
| Resistance Level | $3.82 | $0.71 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 14.21 | 35.77 |
Price Performance
Historical ComparisonAbout XPON Expion360 Inc.
Expion Energy Inc is engaged in premium lithium iron phosphate (LiFePO4) batteries and accessories for recreational vehicles, marine applications, Light EV and industrial applications. The company's lithium-ion batteries feature half the weight of standard lead-acid batteries while delivering three times the power and ten times the number of charging cycles. The company's batteries also feature construction and reliability compared to other lithium-ion batteries on the market due to their superior design and quality materials.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.